Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Tablets
  • 1.3.3 Capsules
  • 1.3.4 Pills
  • 1.3.5 Injections
• 1.4 Market Segment by Application
  • 1.4.1 Global Botanical and Plant Derived Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Online Pharmacies
  • 1.4.5 Drug Stores
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Botanical and Plant Derived Drugs Market Size
  • 2.1.1 Global Botanical and Plant Derived Drugs Revenue 2014-2025
  • 2.1.2 Global Botanical and Plant Derived Drugs Sales 2014-2025
• 2.2 Botanical and Plant Derived Drugs Growth Rate by Regions
  • 2.2.1 Global Botanical and Plant Derived Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Botanical and Plant Derived Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Botanical and Plant Derived Drugs Sales by Manufacturers
  • 3.1.1 Botanical and Plant Derived Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Botanical and Plant Derived Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Botanical and Plant Derived Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Botanical and Plant Derived Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Botanical and Plant Derived Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Botanical and Plant Derived Drugs Price by Manufacturers
• 3.4 Key Manufacturers Botanical and Plant Derived Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Botanical and Plant Derived Drugs Market
• 3.6 Key Manufacturers Botanical and Plant Derived Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Tablets Sales and Revenue (2014-2019)
  • 4.1.2 Capsules Sales and Revenue (2014-2019)
  • 4.1.3 Pills Sales and Revenue (2014-2019)
  • 4.1.4 Injections Sales and Revenue (2014-2019)
• 4.2 Global Botanical and Plant Derived Drugs Sales Market Share by Type
• 4.3 Global Botanical and Plant Derived Drugs Revenue Market Share by Type
• 4.4 Botanical and Plant Derived Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Botanical and Plant Derived Drugs Sales by Application

6 United States

• 6.1 United States Botanical and Plant Derived Drugs Breakdown Data by Company
• 6.2 United States Botanical and Plant Derived Drugs Breakdown Data by Type
• 6.3 United States Botanical and Plant Derived Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Botanical and Plant Derived Drugs Breakdown Data by Company
• 7.2 European Union Botanical and Plant Derived Drugs Breakdown Data by Type
• 7.3 European Union Botanical and Plant Derived Drugs Breakdown Data by Application

8 China

• 8.1 China Botanical and Plant Derived Drugs Breakdown Data by Company
• 8.2 China Botanical and Plant Derived Drugs Breakdown Data by Type
• 8.3 China Botanical and Plant Derived Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Botanical and Plant Derived Drugs Breakdown Data by Company
• 9.2 Rest of World Botanical and Plant Derived Drugs Breakdown Data by Type
• 9.3 Rest of World Botanical and Plant Derived Drugs Breakdown Data by Application
• 9.4 Rest of World Botanical and Plant Derived Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Botanical and Plant Derived Drugs Sales by Countries
  • 9.4.2 Rest of World Botanical and Plant Derived Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Abott Laboratories
  • 10.1.1 Abott Laboratories Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Botanical and Plant Derived Drugs
  • 10.1.4 Botanical and Plant Derived Drugs Product Introduction
  • 10.1.5 Abott Laboratories Recent Development
• 10.2 Bayer Healthcare
  • 10.2.1 Bayer Healthcare Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Botanical and Plant Derived Drugs
  • 10.2.4 Botanical and Plant Derived Drugs Product Introduction
  • 10.2.5 Bayer Healthcare Recent Development
• 10.3 Bionova
  • 10.3.1 Bionova Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Botanical and Plant Derived Drugs
  • 10.3.4 Botanical and Plant Derived Drugs Product Introduction
  • 10.3.5 Bionova Recent Development
• 10.4 Bristol Myers
  • 10.4.1 Bristol Myers Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Botanical and Plant Derived Drugs
  • 10.4.4 Botanical and Plant Derived Drugs Product Introduction
  • 10.4.5 Bristol Myers Recent Development
• 10.5 Curapharm
  • 10.5.1 Curapharm Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Botanical and Plant Derived Drugs
  • 10.5.4 Botanical and Plant Derived Drugs Product Introduction
  • 10.5.5 Curapharm Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Botanical and Plant Derived Drugs Sales Channels
  • 11.2.2 Botanical and Plant Derived Drugs Distributors
• 11.3 Botanical and Plant Derived Drugs Customers

12 Market Forecast

• 12.1 Global Botanical and Plant Derived Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Botanical and Plant Derived Drugs Sales Forecast by Type
• 12.3 Global Botanical and Plant Derived Drugs Sales Forecast by Application
• 12.4 Botanical and Plant Derived Drugs Forecast by Regions
  • 12.4.1 Global Botanical and Plant Derived Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Botanical and Plant Derived Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
Moreover, increasing number of mergers and acquisitions by manufacturing companies is a key trend for botanical and plant derived drugs market.
In 2019, the market size of Botanical and Plant Derived Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Botanical and Plant Derived Drugs.

This report studies the global market size of Botanical and Plant Derived Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Botanical and Plant Derived Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
...

Market Segment by Product Type
Tablets
Capsules
Pills
Injections

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores 

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Botanical and Plant Derived Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Botanical and Plant Derived Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Botanical and Plant Derived Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025